Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Constipation 6Intestinal Diseases 5Pain 3Neoplasms 3Urinary Bladder Neoplasms 2Peritoneal Neoplasms 1Ovarian Neoplasms 1Opioid-Induced Constipation 1Ileus 1Fallopian Tube Neoplasms 1Cancer Pain 1

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × alvimopan × Clear all
NCT06703476 2026-01-27

A Study of Surgical Techniques During Cystectomy

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
530 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03216525 2023-09-28

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

Brigham and Women's Hospital

Phase 3 Recruiting
136 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡